Type 1 Diabetes

Age-appropriate diabetes support for students is detailed, encompassing legal frameworks, healthcare plans, and the essential role of school health teams in effective school management.

In a systematic and meta-analysis review of cohort studies that featured nearly 1.7 million individuals, study authors concluded that there is an association between high body mass index (BMI) and an increased risk of incident type 1 diabetes (T1D).

There are a lot of challenges in the transition from youth to adulthood. For children and teens with chronic diseases like type 1 diabetes, these challenges—and the consequences they bring—only increase.

A new study says yes.

A significant improvement of stimulated C-peptide levels at week 78 for patients newly diagnosed with type 1 diabetes (T1D) was observed for teplizumab-treated patients compared to placebo. Significant differences between groups for insulin dose, percentage of time in target glucose range, and change in glycated hemoglobin were not observed.

From 2006 to 2019, psychotropic medication use for those with type 1 diabetes (T1D) increased, leading investigators to call for risk-benefit studies, further evaluating effectiveness and improved diabetes care in this population.

The number of children who received a T1D diagnosis did not differ from children with and without SARS-CoV-2 infection.

In a recent study, the 2013 WHO criteria for diagnosing gestational diabetes mellitus had a low sensitivity when used in individuals in low-risk early pregnancy.

Surveys collected for a study published in the Canadian Journal of Diabetes revealed that desire for telehealth care amid pediatric diabetes families increased from the early onset of the COVID-19 pandemic, to more than 1 year later.

A recent article reviewed diagnosis and treatment methods of cystic fibrosis-related diabetes in pediatric patients.

The 2023 guideline for managing diabetes in children and adolescents highlights risk factors and treatment for type 1 and type 2 diabetes.

Numerous tools, technology platforms, and interventions have been developed to help teens with the difficult emotional and physical weight of managing the disease.

A new report examined the challenges of diabetes management during the school years from the perspective of the daily social and institutional challenges children face.

A new report reviewed how effective the use of continuous glucose monitors (CGM) was over the course of a year.

Previous studies have suggested that nighttime blood sugar fluctuations are a real problem—and a serious concern—for children with T1D and their parents.

Results of the randomized, multi-site study demonstrated the importance of early diabetes detection, as a single episode of diabetic ketoacidosis (DKA) in young children with type 1 diabetes was associated with lower IQ scores soon after exposure.

Egils K. Bogdanovics, MD, and Schafer Boeder, MD, discuss interpreting antibody test results for type 1 diabetes and provide recommendations for retesting for those who have a negative test or have only 1 antibody present.

Linda A. DiMeglio, MD, reviews screening options for patients with a family history of T1D, highlighting TrialNet.

Expert endocrinologists discuss the clinical symptoms that prompt testing for T1D, as well the diagnostic testing tools that are available in clinical practice.

Justin M. Gregory, MD, MSC, reviews the risk factors of T1D, highlighting a family history of T1D and antibody screening.

Further studies are needed to determine if vaccination should be considered in children at risk for type 1 diabetes (T1D), as a COVID-19 diagnosis among children was associated with an increased incidence of T1D, according to a recent study.

Linda A. DiMeglio, MD, comments on the importance of early diagnosis of T1D, giving patients the advantage of preparing a treatment plan early.

Expert endocrinologists review the importance of staging and classifying T1D, highlighting dysglycemia.

A follow-up to an earlier study, the latest research leveraged EHR data from medical centers in North Carolina and concluded incident cases of type 1 diabetes increased nearly 50% and incident cases of type 2 diabetes more than doubled in 2021-2022 relative to prepandemic years.

Justin M. Gregory, MD, MSC, and Linda A. DiMeglio, MD, provide an overview of the pathophysiology of type 1 diabetes.